National Cardiogenic Shock Initiative (CSI) Protocol

Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...

Dr. Alexander Truesdell: “Team of Teams” for Treating Cardiogenic Shock

Dr. Alex Truesdell of Virginia Heart discusses how a “team of teams” approach to treating cardiogenic shock can standardize car...

Cardiogenic Shock Best Practices

Guidelines for Identifying and Managing AMI Cardiogenic Shock This video reviews...

Volume Management in Cardiogenic Shock Patients

MCS and Volume Considerations in the ICU How do you assess and manage volume in...

Increasing Survival in Cardiogenic Shock through Escalation

Escalation Strategies that Increase Unloading Mark Anderson, MD, discusses how cardiac surger...

Cardiogenic Shock Heart Recovery Case Study

Recovery from STEMI-to-Shock Downward Spiral Alexander Truesdell, MD, presents a case of a 61-year-ol...

Managing Acute MI Cardiogenic Shock

Developing Best Practices with Dr. Bill O’Neill “What are the foundations for developing best practices in managing ac...

Multivessel Versus Culprit Vessel PCI

Is Multivessel PCI with Impella Support Safe in Cardiogenic Shock? Alejandro Lemor, MD, MS, discusses...

Implementing Cardiogenic Shock Protocols

Cardiogenic Shock Protocol Compliance Associated with Survival Joseph Parrillo, MD, discusses impleme...

Cardiogenic Shock Heart Recovery Case Study

Successful Impella® Support Prior to Complete Revascularization Dr. James Park presents his first NCSI...

Impella Use in STEMI Patient

Successful Revascularization in Very Late Stent Thrombosis Case Dr. Sagar Mallikethi Reddy discusses Impella...

National Cardiogenic Shock Initiative Update

Dr. Bill O’Neill Discusses Ongoing Progress in NCSI Bill O’Neill, MD presents some of the overall out...

Techniques to Reduce Bleeding with Large Bore Access Devices

Dr. Amir Kaki Discusses Techniques to Reduce Bleeding Dr. Amir Kaki outlines the factors that have led to reductions i...

Top Cardiogenic Shock Treatment Objectives and Device Options

What is Cardiogenic Shock? Cardiogenic shock is a life-threatening condition that occurs when the heart can no longer...

NCSI Findings Regarding Right Ventricular Dysfunction

About 40% of AMICS Patients Develop Right Ventricular Dysfunction Dr. Babar Basir, an interventionalist at Henry Ford...

Update: What’s New with NCSI

Babar Basir, MD, interventional cardiologist from Henry Ford Hospital, discusses the recent progress made by the National Cardi...

Multicenter Impella Experience Data from Dr. Andreas Schäfer

Impella for AMI Cardiogenic Shock Dr. Andreas Schäfer, an interventional cardiologist and intensivist from Hannover, G...

Case Video: Impella Connect® Was Key to Troubleshooting

Remote Support in a Snowstorm As an early user of...

Duane Pinto Comments on SCAI Vascular Access and Closure Best Practices

A Practical Resource for Practicing Physicians Duane Pinto, MD, MPH, one of the nation’s experts on v...

Shift Toward Door-to-Support

Modern Approaches to AMI Cardiogenic Shock Three clinicians discuss paradigm shifts in the treatment...

Where’s the Cardiogenic Shock Treatment Data?

Looking to Real-world Evidence in Cardiogenic Shock Dr. William O’Neill discusses...

Clinical Paper: Beyond Reperfusion by Jerry Curran

Acute Ventricular Unloading and Cardioprotection During MI Jerry Curran PhD, Senior Scientist at Abio...

WellStar Hub and Spoke Cardiogenic Shock Treatment Network

Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...

The Importance of Early Intervention of Peripartum Cardiomyopathy

Dr. Uri Elkayam discusses Impella Support for PPCM Dr. Uri Elkayam discusses the importance of recogn...

Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women

Reference: J Interven Cardiol 2016; 29:248–256. Card...

Door-to-Unload (DTU) in STEMI Trial Summary

DTU-STEMI Pilot Trial and Pivotal Trial Design Navin K. Kapur, MD, FACC, FSCAI, FAHA, presents a summary of mechanical...

Establishing A Heart Recovery Center

A Significant Step in Managing Cardiogenic Shock Dr. Hiram Bezerra discusses the first heart recovery center...

Case Study Video: Right Ventricular Failure

Impella RP® Support for Univentricular Shock Dr. Navin Kapur, an interventional heart failure specialist at Tufts Medi...

Biventricular Support in Procedural Cardiogenic Shock

Use of Impella RP and Impella 2.5 for MitraClip Procedure Dr. Kamran Muhammad discusses a challenging case illustratin...

Case Review Video: Management of Myocarditis Patient

Impella 5.0® Heart Pump Support Until Transplant Dr. Roberta Bogaev and Dr. Shashank Desai present a case study in whi...

AMI Cardiogenic Shock Management with NCSI Algorithm

Case Study Video with Dr. Inder Singh Dr. Inder Singh presents a case study of a patient with AMI cardiogenic shock wh...

Case Review Video: AMI Cardiogenic Shock

Heart Recovery in AMI Cardiogenic Shock Patients Dr. Bryan Kluck and Dr. Gautam Kumar discuss strategies for managing...

Discussion Video: Management of Cardiogenic Shock in CCU

Managing Impella Patients in the CCU Dr. Joseph Parrillo, Dr. Brian Porvin, and Dr. Steven Keller discuss...

Shock Team Protocols with Dr. Truesdell and Dr. Tehrani

Can anyone do it? Absolutely! Alexander Truesdell, MD, FACC, FSCAI, FSVM and Behnam Tehrani, MD, FSCAI, Medical Direct...

Impella Management in the CCU with Drs. Parrillo, Porvin, and Keller

Inotrope Weaning, Repositioning, Invasive Monitoring, Impella and ECMO Joseph Parrillo, MD, Brian Porvin, DO, and Stev...

INOVA Heart and Vascular Heart Recovery Initiative

Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, intervent...

Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock

“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospital h...

Best Practices for Access and Closure with the Impella® Device

Dr. Shon Chakrabarti joins Dr. Alex Truesdell who talks to us about best practices for vascular access and closure and details...

Quick Tips on Access and Closure

Dr. Alex Truesdell provides his top 3 tips for safe access and closure with the Impella device which include utilizing all of y...

Identifying Cardiogenic Shock Early with a Heart Team Approach

Dr. Alexander Truesdell, Interventional Cardiologist at Inova Heart and Vascular Institute discusses his editorial, the...

Importance of Right Heart Catheterization

Dr. Susan Joseph, Advanced Heart Failure Specialist from Baylor University Medical Center, discusses perspectives on management...

For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI

A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...

Considerations for Impella vs. ECMO

Dr. Michael Tong, Director of Heart Transplantation; Dr. Edward Soltesz, Surgical Director; and Dr. Shinya Unai, Cardiovascular...

Impella RP® Heart Pump Patient Selection Criteria Checklist

Use this checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-796...

Dr. Michael Amponsah Cardiogenic Shock Case with Impella CP

Dr. Michael Amponsah of Central New York Cardiology/Mohawk Valley Health System shares a case of Impella CP for a non-ischemic...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

Best Practice Protocols for Cardiogenic Shock Showing Improved Outcomes Within the WellStar System

Dr. Salvatore Mannino, Director of the Short-Term Mechanical Circulatory Support Program at WellStar Health System joins Dr. Se...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...

Cardiogenic Shock Due to Severe Multi-Vessel Disease

Dr. Alexander Truesdell, Interventional Cardiologist from Inova Heart & Vascular Institute, presents a case of cardiogenic...

Hybrid Closure Technique with Impella

Rajiv Tayal, MD, Director of Structural Heart Disease at JFK Medical Center, presents information from a clinical paper he co-a...

Step-by-Step Guide to Left Heart Unloading with Impella 5.0®

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

Step-by-Step Guide to Right Heart Unloading with Impella RP®

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Left and Right-Side Impella Support in Cardiogenic Shock

Dr. Michael McDaniel of Emory School of Medicine and Dr. Rajesh Sachdeva of Morehouse School of Medicine present a case review...

Identification of Complications and Early Management

Dr. Adhir Shroff of the University of Illinois at Chicago recently presented at the SCAI Fellows 2017 conference during a works...

Heart Team Approach to Treating Cardiogenic Shock

Dr. Alexander Truesdell of INOVA Heart and Vascular Institute compares his experience in combat medicine and combat medical car...

Management of Cardiogenic Shock and Rapid Decision-Making

Dr. Jeffrey Fowler presents a case involving difficult decision-making. This 86 year old patient was otherwise healthy, but pre...

Importance of PA Catheters in Cardiogenic Shock

Drs. Shelley Hall and Ajay Srivastava join Dr. Cathy Jeon to discuss the importance of hemodynamic monitoring in the ICU, parti...

Femoral Access and Explant

Dr. Thomas Tu of Baptist Health Hospital discusses his approach to safely and effectively obtain access in the femoral artery a...

Impella Insertion: Tips & Tricks

Dr. Thomas Tu of Baptist Health Hospital discusses his approach to placing Impella once the sheath has been placed. Dr. Tu outl...

Updates from the Cardiogenic Shock Working Group

Dr. Navin Kapur of Tufts Medical Center and Dr. Mark Anderson of Hackensack University Medical Group join Dr. Seth Bilazarian t...

Escalation of Support and Algorithms for Cardiogenic Shock

Dr. Mark Anderson joins Dr. Dan Raess to discuss improvements outcomes for patients in cardiogenic shock through the early use...

Q&A: Patient Selection for Impella® Heart Pump Support

Dr. Adhir Shroff outlines the patients that his team sees in clinical practice and how they identify patients who are candidate...

Complications Management: Hemolysis in AMI Complicated by Cardiogenic Shock

Dr. Jeffrey Fowler of the University of Pittsburg Medical Center presents a case describing a patient who had been in the CCU f...

Large Bore Access: Q&A with Dr. Adhir Shroff

Dr. Adhir Shroff discusses key elements of large bore femoral access. He details his experience with identifying appropriate ac...

Groin Management at the Impella® Heart Pump Access Site

Dr. Jeffrey Fowler discusses how to handle oozing at the groin access site. He reviews a case of an 81 year old male with hyper...

TCT-Cardiogenic Shock Initiative

“This is a call to action to American interventional cardiologists and American cardiology leaders to try to come u...

A Retrospective Analysis Suggests Early Impella® Device Placement Confers Better Outcomes in High-Risk PCI and Cardiogenic Shock

Dr. Ashish Pershad of Banner University Medical Center in Phoenix, Arizona, discusses his recent retrospective study published...

Exchanging a Balloon Pump with the Impella CP® Heart Pump: Case Review

In this case presentation, Dr. Shon (Anjan) Chakrabarti of the Sentara Heart Hospital in Norfolk, VA, discusses the use of the...

Updates on the Detroit Cardiogenic Shock Initiative: It’s Gone National

Dr. Bill O’Neill of Henry Ford Hospital and Dr. Ted Schreiber of Detroit Medical Center discuss updates on the Detroit Cardioge...

Adopting a Protocol for Cardiogenic Shock – Pitfalls and Pathways to Success

By Dr. Cathy Jeon, Abiomed Medical Director   Successfully treating cardiogenic shock requires getting a m...

Dr. Bill O’Neill Discusses Recovery Time from RV and LV Shock with Impella RP® Support

In this physician Q&A session, Dr. Bill O’Neill discusses recovery considerations as well as time to recovery following Imp...

Large Bore Access with Impella CP® and New 25 Centimeter Sheath

Dr. Sahil Parikh draws on his extensive experience to share best practices on large bore vascular access. “I...

Renal Considerations in Cardiogenic Shock

Dr. Anand Prasad, of University of Texas Health Science Center, draws on his experience with cardiac and renal disease to share...

Case Review: AMI Cardiogenic Shock using Impella CP® Heart Pump Support on a Left Main During Orbital Atherectomy

Dr. David Lasorda of Allegheny General Hospital presents a case of AMI cardiogenic shock using Impella CP® Heart Pump Support o...

Alternative Access: Percutaneous Axillary Impella® Placement with Dr. Raj Tayal

Dr. Raj Tayal of Newark Beth Israel Medical Center draws on his experience in...

Dr. Behnam Tehrani on After Action Reviews, a Process to Evaluate and Enhance Future Performance

Dr. Behnam Tehrani of Inova Heart and Vascular Institute explains an After Action Review (AAR) program to evaluate the shock pr...

Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala

Michael Hacala, Detroit Cardiogenic Shock (DCSI) Coordinator at Henry Ford Hospital. Tune in to hear updates about the program,...

Specialist Opinion: Dr. Perwaiz Meraj

Dr. Perwaiz Meraj of Northwell Health discusses a new study demonstrating potential survival with Impella 2.5®...

Abiomed’s Cardiogenic Shock Guidelines

The use of standardized protocols has been associated with improvement in outcomes for people in...

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA i...